Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare In Brief

This article was originally published in The Gray Sheet

Executive Summary

Comments on PET for solid tumors, myeloma: Physicians and specialty societies are urging CMS to reconsider Medicare policy that allows doctors to perform only one positron emission tomography scan when planning initial radiation treatment in patients with solid tumors or myeloma. "The current 'one scan' restriction precludes obtaining the specially aligned PET scan that is required for radiation treatment planning," says David Milstein, M.D., Albert Einstein College of Medicine. America's Health Insurance Plans, however, argues against additional PET scans without evidence that second tests are necessary to make treatment decisions and that those decisions improve health outcomes. The Academy of Molecular Imaging suggests "it is possible to extend coverage for certain limited radiation therapy purposes ... without allowing the exception to consume the rule." CMS opened its national coverage analysis in November and will issue a proposed decision by May 9, 2010 (1"The Gray Sheet" Nov. 16, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel